Portman »

Rapt Therapeutics shares owned by Portman

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Portman from 13F filings

Historical chart of Portman investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Portman consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Portman

Quarter filed Position value Share count Share price at filing
2022-09-30 $307k 13k 24.05

More positions owned by Portman

Pinduoduo Sponsored Ads (PDD)
Uipath Cl A (PATH)
Freshworks Class A Com (FRSH)
Airbnb Com Cl A (ABNB)
Rapt Therapeutics (RAPT)

View all positions for Portman

Top funds holding Rapt Therapeutics

T. Rowe Price Associates
Column Group
Perceptive Advisors
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Kingdon Capital Management
Samlyn Capital
Euclidean Capital
Alphabet
Cormorant Asset Management
Dimensional Fund Advisors
Millennium Management
Citadel Advisors
Braidwell
Redmile Group

View all funds holding Rapt Therapeutics